 Ultragenyx Pharmaceutical Inc. NASDAQ:RARE Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Joshua Higa - Head of Investor Relations Emil Kakkis - Founder, President and Chief Executive Officer Erik Harris - Executive Vice President and Chief Commercial Officer Mardi Dier - Executive Vice President and Chief Financial Officer Camille Bedrosian - Executive Vice President and Chief Medical Officer Conference Call Participants Gena Wang - Barclays Joori Park - SVB Securities LLC Christopher Raymond - Piper Sandler Tazeen Ahmad - Bank of America Merrill Lynch Dae Gon Ha - Stifel Maurice Raycroft - Jefferies LLC Yigal Nochomovitz - Citigroup Inc. Joon Lee - Truist Securities Yaron Werber - Cowen and Company, LLC Elizabeth Webster - Goldman Sachs Group, Inc. Joel Beatty - Robert W. Baird Company, Inc. Liisa Bayko - Evercore ISI Operator Thank you for standing by. 